Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2023-05-05 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Book Closure
Regulatory Filings Classification · 100% confidence The document text is extremely short (134 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2023-05-05 English
Record Date
Regulatory Filings Classification · 100% confidence The document text is extremely short (134 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2023-05-05 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal communication from Rossari Biotech Limited to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on May 5, 2023. It details the approval of convening the 14th Annual General Meeting (AGM), the record date for dividend payment, appointment of internal auditors, and recommendation for appointment of statutory auditors. The document references compliance with SEBI Listing Regulations and includes annexures with detailed information about the auditor appointments. The content is an announcement of board decisions and compliance disclosures rather than the full annual report or financial statements. It does not contain financial data or detailed management discussion but rather informs stakeholders of board meeting outcomes and upcoming AGM details. Therefore, it fits the category of Board/Management Information (MANG) as it announces changes and decisions made by the board, including auditor appointments and AGM scheduling.
2023-05-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (188 characters) and contains only a digital signature and omitted images, with no substantive text or financial data. There is no indication of a full report, announcement, or detailed filing. It does not contain any financial statements, regulatory content, or report titles. Given the brevity and lack of content, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-05-02 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of extracts of consolidated audited financial results for the quarter and financial year ended March 31, 2023. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulations 30 and 47, which pertain to disclosure of financial results. The document includes newspaper publication extracts of these financial results. The document is not the full financial report itself but an announcement of the publication of extracts of the audited financial results. The length is about 15,000 characters, but the content is primarily a notification letter with attached newspaper extracts, not the full financial statements or detailed analysis. Therefore, this fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication rather than the full Annual Report (10-K) or Interim Report (IR).
2023-05-01 English
Press Release
Earnings Release Classification · 95% confidence The document is a detailed announcement of Rossari Biotech Limited's financial results for the quarter and full fiscal year ended March 31, 2023. It includes consolidated and standalone revenue, EBITDA, PAT, and EPS figures, along with comparative analysis to previous periods. The document also contains management commentary on performance, key developments including acquisition completion, and dividend declaration. The presence of comprehensive financial data and performance analysis for a full fiscal year indicates this is a full financial results announcement rather than a brief earnings highlight or a simple announcement of report publication. Therefore, this document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights. The document length (8922 characters) and content confirm it is not a mere announcement or regulatory filing. Hence, the classification is ER with high confidence. FY 2023
2023-04-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.